Full-Time

Sr Director

Clinical Development

Updated on 1/10/2025

Tarsus Pharamceuticals

Tarsus Pharamceuticals

201-500 employees

Develops treatments for eye care diseases

Biotechnology
Healthcare

Compensation Overview

$240k - $336kAnnually

+ Bonus + Stock Equity

Expert

Irvine, CA, USA

Hybrid work environment; requires in-office presence.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • Advanced degree(s) in relevant field: PharmD, MD or MD/PhD
  • Deep clinical expertise in Ophthalmology
  • Minimum of 15 years professional pharmaceutical clinical development experience
  • Minimum of 10 years leadership in clinical trial management experience
  • Extensive experience in early clinical development of ophthalmology
  • Understanding of working in a smaller company
  • Experienced in industry with expertise in clinical trial design and execution
  • Experienced with early to late stage clinical trials
  • Familiarity with the IND to NDA process
  • External focus to understand trends in the disease area and treatment paradigms
  • Ability to build relationships with external partners, thought leaders, and collaborators
  • Established leadership track record with evidence of excellent performance-based people management experience
  • Problem solving, collaboration, cross functional leadership, and effective communication skills
  • Positive communication style with a can-do attitude and strong work ethic
  • Organized with a systematic approach to prioritization
  • Ability to work collaboratively to project plan, problem solve and deliver results
  • Expertise with SOPs, GCPs and regulatory and compliance guidelines for clinical trials
  • Significant knowledge of clinical and outcomes research study design
  • Proficient knowledge of medical terminology and clinical research industry
Responsibilities
  • Provides leadership, scientific and strategic planning, direction, and implementation of clinical development activities.
  • Provides clinical leadership and disease area expertise into integrated disease area strategies.
  • Partners closely with KOLs in specific indications.
  • Evaluates strategic options against a given Target Product Profile (TPP).
  • Establishes clinical strategies and designs clinical trial protocols that can rapidly and robustly assess proof-of-concept in early trials as well as designing late stage trials.
  • Leads the clinical science team and oversees the strategy, planning, and resourcing of clinical research activities and clinical trials.
  • Leads and oversees the training of study investigators on protocol and on clinical trial procedures.
  • Authors CSRs, SAPs, Protocols, Clinical Value dossiers, IBs, DSURs, ICFs etc.
  • Leads the analysis and interpretation of clinical data to inform strategic decision-making, identifying trends, and ensure data insights communicated effectively.
  • Conducts research to develop foundational educational material to inform the program strategies.
  • Provides leadership and strategic oversight in the determination of study objectives, strategy, scope, and schedule to meet business needs; align the team on common priorities and initiatives.
  • Partners across functional lines with clinical operations, regulatory affairs, clinical pharmacology, statistics, project management, preclinical science, and others as needed.
  • Serves as program lead on Core teams, investigator meetings, and scientific advisory boards.
  • Ensures the leadership team is kept informed of study progress and that all critical issues are appropriately escalated within the organization.
  • Define and negotiating the scope of work (SOW), budget, pricing, and payment schedules for the clinical vendors.
  • Leads innovation by identifying and integrating cutting-edge technologies and methodologies into clinical trial design.
Tarsus Pharamceuticals

Tarsus Pharamceuticals

View

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company is also working on other potential treatments for conditions such as Lyme Disease Prevention, Meibomian Gland Disease, and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong pipeline of future products. Their goal is to provide effective treatments for patients suffering from these conditions while ensuring compliance with regulations and ethical standards.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

Irvine, California

Founded

2017

Growth & Insights
Headcount

6 month growth

5%

1 year growth

0%

2 year growth

6%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing awareness of Demodex blepharitis expands market for Tarsus's XDEMVY.
  • Telemedicine rise offers new marketing opportunities for Tarsus's products.
  • FDA's focus on unmet needs may expedite Tarsus's pipeline approvals.

What critics are saying

  • Increased competition in ophthalmic treatments challenges Tarsus's market position.
  • Potential clinical trial delays could affect Tarsus's product pipeline.
  • Supply chain constraints may hinder XDEMVY's production and distribution.

What makes Tarsus Pharamceuticals unique

  • Tarsus focuses on high unmet needs in ophthalmic and infectious diseases.
  • Their lead product, XDEMVY, is FDA-approved for Demodex blepharitis treatment.
  • Tarsus's pipeline includes innovative treatments for Lyme disease and Rosacea.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Hybrid Work Options

Professional Development Budget